US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 0.587
  • +0.037+6.75%
Close Apr 29 16:00 ET
  • 0.559
  • -0.028-4.77%
Post 17:29 ET
3.41MMarket Cap-5P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.67%-18.07M
-40.89%-5.66M
20.72%-3.51M
-30.23%-4.39M
-14.31%-4.51M
-199.28%-15.76M
-151.11%-4.02M
-44.13%-4.42M
-4,337.16%-3.37M
-656.21%-3.95M
Net income from continuing operations
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
-84.13%-4.29M
-268.58%-4.67M
22.64%-3.47M
Depreciation and amortization
424.05%516.75K
375.08%140.17K
459.56%138.78K
506.18%137.59K
363.86%100.2K
132.18%98.61K
1.78%29.51K
229.16%24.8K
383.66%22.7K
1,622.57%21.6K
Change In working capital
-182.69%-1.08M
-312.35%-2.03M
580.57%1.26M
-130.83%-363.12K
107.92%44.42K
179.56%1.31M
-15.36%954.27K
66.12%-262.82K
472.47%1.18M
-528.22%-560.67K
-Change in receivables
200.00%360.23K
--0
--0
--0
--360.23K
---360.23K
--127.65K
---453.15K
---34.73K
--0
-Change in prepaid assets
351.25%362.91K
-3.35%232.64K
67.46%-600.02K
5.18%1.4M
-641.83%-673.21K
92.41%-144.44K
-69.84%240.71K
17.82%-1.84M
7,254.49%1.33M
126.12%124.25K
-Change in payables and accrued expense
-170.29%-1.3M
-442.55%-2.09M
-3.69%1.96M
-1,329.90%-1.74M
184.96%575.98K
-21.23%1.84M
17.45%609.45K
35.64%2.03M
-89.85%-121.93K
-275.47%-677.93K
-Change in other current assets
---111.86K
--0
--0
--0
---111.86K
--0
--0
--0
--0
--0
-Change in other current liabilities
---424.39K
---144.12K
---68.6K
---104.94K
---106.72K
--0
--0
--0
--0
--0
-Change in other working capital
188.63%27.06K
-15.77%-27.25K
---27.44K
----
----
-200.00%-30.53K
87.58%-23.54K
--0
--0
---6.99K
Cash from discontinued investing activities
Operating cash flow
-14.67%-18.07M
-40.89%-5.66M
20.72%-3.51M
-30.23%-4.39M
-14.31%-4.51M
-199.28%-15.76M
-151.11%-4.02M
-44.13%-4.42M
-4,337.16%-3.37M
-656.21%-3.95M
Investing cash flow
Cash flow from continuing investing activities
64.72%-35.61K
0
-4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
0
-89.06%-42.05K
59.29%-30.66K
Net PPE purchase and sale
64.72%-35.61K
--0
---4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
--0
-89.06%-42.05K
59.29%-30.66K
Cash from discontinued investing activities
Investing cash flow
64.72%-35.61K
--0
---4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
--0
-89.06%-42.05K
59.29%-30.66K
Financing cash flow
Cash flow from continuing financing activities
265,542.41%15.91M
333.16%978.15K
3,372.94%7.39M
6.36M
19,614.24%1.18M
-99.98%5.99K
2,280.78%225.82K
-100.88%-225.82K
0
104.55%5.99K
Net common stock issuance
--15.91M
--978.15K
--7.26M
--6.5M
--1.18M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
-79.54%5.99K
--0
--0
--0
--5.99K
Cash from discontinued financing activities
Financing cash flow
265,542.41%15.91M
333.16%978.15K
3,372.94%7.39M
--6.36M
19,614.24%1.18M
-99.98%5.99K
2,280.78%225.82K
-100.88%-225.82K
--0
104.55%5.99K
Net cash flow
Beginning cash position
-76.14%4.97M
-15.22%7.45M
-73.42%3.57M
-90.37%1.62M
-76.14%4.97M
2,415.15%20.83M
-60.93%8.79M
16,789.40%13.44M
16,929.39%16.85M
2,415.15%20.83M
Current changes in cash
86.12%-2.2M
-22.58%-4.69M
183.49%3.88M
157.11%1.95M
15.79%-3.35M
-179.30%-15.86M
-128.32%-3.82M
-120.73%-4.65M
-17,503.72%-3.41M
-444.98%-3.97M
End cash Position
-44.30%2.77M
-44.30%2.77M
-15.22%7.45M
-73.42%3.57M
-90.37%1.62M
-76.14%4.97M
-76.14%4.97M
-60.93%8.79M
16,789.40%13.44M
16,929.39%16.85M
Free cash flow
-14.16%-18.11M
-39.91%-5.66M
20.62%-3.51M
-29.16%-4.41M
-13.75%-4.53M
-187.29%-15.86M
-140.02%-4.05M
-40.85%-4.42M
-3,375.44%-3.41M
-566.03%-3.98M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.67%-18.07M-40.89%-5.66M20.72%-3.51M-30.23%-4.39M-14.31%-4.51M-199.28%-15.76M-151.11%-4.02M-44.13%-4.42M-4,337.16%-3.37M-656.21%-3.95M
Net income from continuing operations -5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M-84.13%-4.29M-268.58%-4.67M22.64%-3.47M
Depreciation and amortization 424.05%516.75K375.08%140.17K459.56%138.78K506.18%137.59K363.86%100.2K132.18%98.61K1.78%29.51K229.16%24.8K383.66%22.7K1,622.57%21.6K
Change In working capital -182.69%-1.08M-312.35%-2.03M580.57%1.26M-130.83%-363.12K107.92%44.42K179.56%1.31M-15.36%954.27K66.12%-262.82K472.47%1.18M-528.22%-560.67K
-Change in receivables 200.00%360.23K--0--0--0--360.23K---360.23K--127.65K---453.15K---34.73K--0
-Change in prepaid assets 351.25%362.91K-3.35%232.64K67.46%-600.02K5.18%1.4M-641.83%-673.21K92.41%-144.44K-69.84%240.71K17.82%-1.84M7,254.49%1.33M126.12%124.25K
-Change in payables and accrued expense -170.29%-1.3M-442.55%-2.09M-3.69%1.96M-1,329.90%-1.74M184.96%575.98K-21.23%1.84M17.45%609.45K35.64%2.03M-89.85%-121.93K-275.47%-677.93K
-Change in other current assets ---111.86K--0--0--0---111.86K--0--0--0--0--0
-Change in other current liabilities ---424.39K---144.12K---68.6K---104.94K---106.72K--0--0--0--0--0
-Change in other working capital 188.63%27.06K-15.77%-27.25K---27.44K---------200.00%-30.53K87.58%-23.54K--0--0---6.99K
Cash from discontinued investing activities
Operating cash flow -14.67%-18.07M-40.89%-5.66M20.72%-3.51M-30.23%-4.39M-14.31%-4.51M-199.28%-15.76M-151.11%-4.02M-44.13%-4.42M-4,337.16%-3.37M-656.21%-3.95M
Investing cash flow
Cash flow from continuing investing activities 64.72%-35.61K0-4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K0-89.06%-42.05K59.29%-30.66K
Net PPE purchase and sale 64.72%-35.61K--0---4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K--0-89.06%-42.05K59.29%-30.66K
Cash from discontinued investing activities
Investing cash flow 64.72%-35.61K--0---4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K--0-89.06%-42.05K59.29%-30.66K
Financing cash flow
Cash flow from continuing financing activities 265,542.41%15.91M333.16%978.15K3,372.94%7.39M6.36M19,614.24%1.18M-99.98%5.99K2,280.78%225.82K-100.88%-225.82K0104.55%5.99K
Net common stock issuance --15.91M--978.15K--7.26M--6.5M--1.18M--0--0--0--0--0
Proceeds from stock option exercised by employees --0--0--0--0--0-79.54%5.99K--0--0--0--5.99K
Cash from discontinued financing activities
Financing cash flow 265,542.41%15.91M333.16%978.15K3,372.94%7.39M--6.36M19,614.24%1.18M-99.98%5.99K2,280.78%225.82K-100.88%-225.82K--0104.55%5.99K
Net cash flow
Beginning cash position -76.14%4.97M-15.22%7.45M-73.42%3.57M-90.37%1.62M-76.14%4.97M2,415.15%20.83M-60.93%8.79M16,789.40%13.44M16,929.39%16.85M2,415.15%20.83M
Current changes in cash 86.12%-2.2M-22.58%-4.69M183.49%3.88M157.11%1.95M15.79%-3.35M-179.30%-15.86M-128.32%-3.82M-120.73%-4.65M-17,503.72%-3.41M-444.98%-3.97M
End cash Position -44.30%2.77M-44.30%2.77M-15.22%7.45M-73.42%3.57M-90.37%1.62M-76.14%4.97M-76.14%4.97M-60.93%8.79M16,789.40%13.44M16,929.39%16.85M
Free cash flow -14.16%-18.11M-39.91%-5.66M20.62%-3.51M-29.16%-4.41M-13.75%-4.53M-187.29%-15.86M-140.02%-4.05M-40.85%-4.42M-3,375.44%-3.41M-566.03%-3.98M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg